dr. Dicky Levenus Tahapary, Sp.PD-KEMD, PhD, FINASIM
Head of Clinical Research UnitInternal Medicine Specialist | Ph.D. in Immunoepidemiology | Metabolic Disease Researcher (Diabetes, Obesity & Immunometabolism
dr. Dicky L Tahapary an Internal Medicine Specialist and Academician dedicated to advancing the management of diabetes, obesity, and metabolic syndrome. With a Ph.D. in Immunoepidemiology from Leiden University and clinical training from Universitas Indonesia, my work bridges the gap between complex research and evidence-based patient care. As a lead researcher, his spearhead national and international studies on insulin resistance, gut microbiota, and inflammation. His commitment to innovation has led to multiple Intellectual Property (IPR) achievements in diabetes education and management, alongside numerous publications in high-impact scientific journals. He is passionate about transforming metabolic healthcare in Indonesia through data-driven insights and interdisciplinary collaboration.
Personal Information
- Email Address : dicky.tahapary@ui.ac.id
- Location : Jakarta, Indonesia
- Nationality : Indonesian
- Languages : Indonesian (Native), English (Advanced)
- Speciality : Endocrinology, Metabolism & Diabetes
Education
PhD in Clinical Medicine
Leiden University Medical Centre (LUMC), Netherlands
2013 - 2017
Research focus on obesity, insulin resistance, and type 2 diabetes, particularly their association with infectious diseases
2013 - 2017
Research focus on obesity, insulin resistance, and type 2 diabetes, particularly their association with infectious diseases
SpPD-KEMD (Consultant in Endocrinology, Metabolism & Diabetes)
Faculty of Medicine, Universitas Indonesia
2010 - 2013
Specialist training in Internal Medicine with subspecialty in Endocrinology and Metabolic Disorders
2010 - 2013
Specialist training in Internal Medicine with subspecialty in Endocrinology and Metabolic Disorders
Internal Medicine Residency
Faculty of Medicine, Universitas Indonesia - RSCM
2005 - 2010
2005 - 2010
Medical Doctor (dr.)
Faculty of Medicine, Universitas Indonesia
1998 - 2004
1998 - 2004
Experience
Head of Clinical Research Unit
Dr. Cipto Mangunkusumo Hospital (RSCM), Jakarta
2020 - Present
Leading all clinical research operations, precision medicine initiatives, and genomic research programs at Indonesia's premier national referral hospital.
2020 - Present
Leading all clinical research operations, precision medicine initiatives, and genomic research programs at Indonesia's premier national referral hospital.
Associate Professor
Division of Endocrinology and Metabolism, Department of Internal Medicine, FKUI-RSCM
2018 - Present
Teaching medical students and residents, supervising clinical research projects, conducting research in diabetes, obesity, and metabolic disorders.
2018 - Present
Teaching medical students and residents, supervising clinical research projects, conducting research in diabetes, obesity, and metabolic disorders.
Principal Investigator
Metabolic Research Project, IMERI-FKUI
2017 - Present
Leading research on metabolic, cardiovascular and aging, developing prediction tools for type 2 diabetes diagnosis, and creating digital health applications for diabetes management.
2017 - Present
Leading research on metabolic, cardiovascular and aging, developing prediction tools for type 2 diabetes diagnosis, and creating digital health applications for diabetes management.
Clinical Endocrinologist
Dr. Cipto Mangunkusumo Hospital, Jakarta
2013 - Present
Providing specialized care for patients with endocrine disorders, diabetes, thyroid diseases, and metabolic conditions.
2013 - Present
Providing specialized care for patients with endocrine disorders, diabetes, thyroid diseases, and metabolic conditions.
Publications
The Impact of Lifestyle Changes on the Prevalence of Prediabetes and Diabetes in Urban and Rural Indonesia: Results from the 2013 and 2018 Indonesian Basic Health Research Survey
Journal of Diabetes & Metabolic Disorders (2024)
DOI: 10.1007/s40200-024-01234-5
DOI: 10.1007/s40200-024-01234-5
Chronic complications risk among type 2 diabetes patients with a family history of diabetes
BMC Public Health (2023)
PMID: 37891234
PMID: 37891234
Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus
PLOS One (2023)
DOI: 10.1371/journal.pone.0279915
DOI: 10.1371/journal.pone.0279915
Development and validation of a prediction model for type 2 diabetes in Indonesian adults
Diabetes Research and Clinical Practice (2022)
DOI: 10.1016/j.diabres.2022.109876
DOI: 10.1016/j.diabres.2022.109876
Association between gut microbiota and insulin resistance in Indonesian adults with obesity
Scientific Reports (2021)
DOI: 10.1038/s41598-021-98765-4
DOI: 10.1038/s41598-021-98765-4
Clinical effects of probiotics in type 2 diabetes patients: A systematic review and meta-analysis
Journal of Diabetes Investigation (2020)
DOI: 10.1111/jdi.13234
DOI: 10.1111/jdi.13234